BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gijs M, Ramakers IHGB, Visser PJ, Verhey FRJ, van de Waarenburg MPH, Schalkwijk CG, Nuijts RMMA, Webers CAB. Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration. Sci Rep 2021;11:22675. [PMID: 34811435 DOI: 10.1038/s41598-021-01993-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lin CW, Lai TT, Chen SJ, Lin CH. Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease. Geroscience 2022. [PMID: 35484471 DOI: 10.1007/s11357-022-00576-6] [Reference Citation Analysis]
2 Jung DH, Son G, Kwon O, Chang K, Moon C. Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease. Pharmaceutics 2022;14:1532. [DOI: 10.3390/pharmaceutics14081532] [Reference Citation Analysis]
3 Mahaman YAR, Embaye KS, Huang F, Li L, Zhu F, Wang JZ, Liu R, Feng J, Wang X. Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention. Ageing Res Rev 2022;74:101544. [PMID: 34933129 DOI: 10.1016/j.arr.2021.101544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Romaus-Sanjurjo D, Regueiro U, López-López M, Vázquez-Vázquez L, Ouro A, Lema I, Sobrino T. Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration. Int J Mol Sci 2022;23:2486. [PMID: 35269629 DOI: 10.3390/ijms23052486] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]